Desferrioxamine modulates chemically induced T helper 2-mediated autoimmunity in the rat

Clinical and Experimental Immunology

Volumn 135, Issue 2, 2004, Pages 194-199

  Wu, Z ^a,b   Holwill, S D J ^a   Oliveira, D B G ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b Cranmer Terrace ^*  (United Kingdom)

Author keywords

Animal model; Antioxidant; IgE; Interleukin 4; Vasculitis

Indexed keywords

ANTIOXIDANT; DEFEROXAMINE; IMMUNOGLOBULIN E; INTERLEUKIN 4; MERCURIC CHLORIDE; THIOL DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CECUM; CONTROLLED STUDY; GENE EXPRESSION; HELPER CELL; IMMUNOGLOBULIN PRODUCTION; LYMPHOCYTE PROLIFERATION; MALE; MODULATION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RAT; RAT STRAIN; TISSUE INJURY; VASCULITIS;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; DEFEROXAMINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; IMMUNOGLOBULIN E; INTERFERON TYPE II; INTERLEUKIN-4; IRON CHELATING AGENTS; MALE; MERCURIC CHLORIDE; OXIDATIVE STRESS; RATS; RATS, INBRED BN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPLEEN; TH2 CELLS; VASCULITIS;

EID: 0842287206     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2003.02372.x     Document Type: Article

References (31)

1. Burrows B, Martinez FD, Halonen M et al. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med 1989; 320:271-7.
2. Kleinjan A, Vinke JG, Severijnen LW et al. Local production and detection of (specific) IgE in nasal B-cells and plasma cells of allergic rhinitis patients. Eur Respir J 2000; 3:491-7.
3. Ying S, Humbert M. Meng et al. Local transcription of ε germline gene transcripts and RNA for the ε heavy chain of IgE in the bronchial mucosa in atopic and nonatopic asthma. J Allergy Clin Immunol 2001; 107:686-92.
4. Fallon PG, Jolin HE, Smith P et al. IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9, and IL-13. Immunity 2002; 17:7-17.
5. Ferlin WG, Severinson E, Strom L et al. CD40 signaling induces interleukin-4-independent IgE switching in vivo. Eur J Immunol 1996; 26:2911-5.
6. Faty JV. Reducing IgE levels as a strategy for the treatment of asthma. Clin Exp Allergy 2000; 30 (Suppl. 1):16-21.
7. Esnault VLM, Mathieson PW, Thiru S et al. Autoantibodies to myeloperoxidase in Brown Norway rats treated with mercuric chloride. Lab Invest 1992; 67:114-20.
8. Goldman M, Druet P, Gleichmann E. Th2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically-induced autoimmunity. Immunol Today 1991; 12:223-7.
9. Kiely PDW, Thiru S, Oliveira DBG. Inflammatory polyarthritis induced by mercuric chloride in the Brown Norway rat. Lab Invest 1995; 73:284-93.
10. Jennette JC, Falk RJ, Milling DM. Pathogenesis of vasculitis. Semin Neurol 1994; 14:291-9.
11. Cohen Tervaert JW, Limburg PC, Elema JD et al. Detection of autoantibodies against myeloid lysosomal enzymes: a useful adjunct to classification of patients with biopsy-proven necrotizing arteritis. Am J Med 1991; 91:59-66.
12. Pelletier L, Pasquier R, Rossert J et al. Autoreactive T cells in mercury-induced autoimmunity: ability to induced the autoimmune disease. J Immunol 1988; 140:2335-41.
13. Finkelman FD, Katona IM, Urban JF et al. IL-4 is required to generate and sustain in vivo IgE responses. J Immunol 1988; 141:2335-41.
14. Wu Z, Turner DR, Oliveira DBG. Antioxidants inhibit mercuric chloride-induced early vasculitis. Int Immunol 2002; 14:267-73.
15. Kiely PDW, Pecht I, Oliveira DBG. Mercuric chloride-induced vasculitis in the Brown Norway rat: αβ T cell dependent and independent phases - role of the mast cell. J Immunol 1997; 159:5100-6.
16. Wu Z, Turner DR, Oliveira DBG. Interleukin (IL)-4 gene expression upregulated by mercury in rat mast cells: a role of oxidant stress in IL-4 transcription. Int Immunol 2001; 13:297-304.
17. Qasim FJ, Mathieson PW, Thiru S et al. Cyclosporin A exacerbates mercuric chloride-induced vasculitis in the Brown Norway rat. Laboratory Invest 1995; 72:183-90.
18. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-9.
19. Qasim FJ, Mathieson PW, Thiru S et al. Time course and characterisation of mercuric chloride induced autoimmunity in the Brown Norway rat. J Autoimmun 1995; 8:195-208.
20. Morel PA, Oriss TB. Crossregulation between Th1 and Th2 cells. Crit Rev Immmunol 1998; 18:275-303.
21. + T-cell responses against malaria liver stages. Nat Med 2002; 8:166-70.
22. Gillespie KM, Saoudi A, Kuhn J et al. Th1/Th2 cytokine gene expression after mercuric chloride in susceptible and resistant rat strains. Eur J Immunol 1996; 26:2388-92.
23. Jeannin P, Delneste Y, Lecoanet-Henchoz S et al. Thiols decrease human interleukin (IL) 4 production and IL-4-induced immunoglobulin synthesis. J Exp Med 1995; 182:1785-92.
24. 2-iodide cytotoxic system. J Exp Med 1982; 156:1262-7.
25. Wolfreys K, Oliveira DBG. Alterations in intracellular reactive oxygen species generation and redox potential modulate mast cell function. Eur J Immunol 1997; 27:297-306.
26. MacCarthy PA, Grieve DJ, Li J et al. Impaired endothelial regulation of ventricular relaxation in cardiac hypertropy. Circulation 2001; 104:2967-74.
27. Nitenberg A, Ledoux S, Valensi P et al. Coronary microvascular adaptation to myocardial metabolic demand can be restored by inhibition of iron-catalyzed formation of oxygen free radicals in type 2 diabetic patients. Diabetes 2002; 51:813-8.
28. Rudge EU, Cutler AJ, Pritchard NR et al. Interleukin 4 reduces expression of inhibitory receptors on B cells and abolishes CD22 and FcrRII-mediated B cell suppression. J Exp Med 2002; 195:1079-85.
29. Gillespie KM, Qasim LM, Tibbatts LM et al. Interleukin-4 gene expression in mercury-induced autoimmunity. Scand J Immunol 1995; 41:268-72.
30. Bradding P, Feather IH, Howarth PH et al. Interleukin 4 is localized to and released by human mast cells. J Exp Med 1992; 176:1381-6.
31. Bird JJ, Brown DR, Mullen AC et al. Helper T cell differentiation is controlled by the cell cycle. Immunity 1998; 9:229-37.